Cerebrospinal fluid gamma interferon (IFN-␥) and interleukin-10 levels in 39 patients with tuberculous meningitis were serially measured. Cytokine levels did not predict intracranial granuloma (IG) development, but IFN-␥ levels in the top quartile after 1 month of therapy were highly associated (odds ratio ؍ 18) with detection of an IG by computed tomography scanning.Cytokines such as gamma interferon (IFN-␥) and tumor necrosis factor alpha play a pivotal role in the development of granulomas in pulmonary tuberculosis (1,11,13). Similar mechanisms presumably mediate intracranial granuloma (IG) formation in patients with tuberculous meningitis (TBM), but as of yet, the relationship has not been well characterized. We therefore sought to determine whether IG formation could be predicted on the basis of cerebrospinal fluid levels of these two cytokines.Study patients were a subset of a TBM treatment trial conducted at the Abbassia Fever Hospital in Cairo, Egypt. For the treatment trial, patients received daily isoniazid (INH) (10 mg/kg of body weight/day; maximum, 300 mg/day), rifampin (20 mg/kg/day; maximum, 600 mg/day), pyrazinamide (40 mg/ kg/day; maximum, 1,000 mg), and streptomycin (15 mg/kg/day; maximum, 1,000 mg) for 2 months followed by daily INH and rifampin. Oral dexamethasone (0.4 mg/kg/day) was administered for the first month of therapy, and then the dosage was tapered over the next month.Inclusion in the present study required a pretreatment cerebrospinal fluid (CSF) culture positive for Mycobacteria tuberculosis plus an aliquot of CSF collected prior to initiation of antituberculous therapy and 1 month later. When available, CSF collected 6 months after initiation of therapy was also tested for cytokines. CSF IFN-␥ and interleukin-10 (IL-10) concentrations were determined at the University of Arkansas by use of enzyme-linked immunoassay kits (R and D Systems, Minneapolis, Minn.). The detection limits of the assays were 8 pg/ml for IFN-␥ and 4 pg/ml for IL-10. All samples were analyzed undiluted in duplicate according to the manufacturer's instructions and reanalyzed when variability between duplicates was greater than 20%, which occurred in Ͻ3% of the samples tested.Computed tomography (CT) brain scans, obtained prior to and after administration of urographin contrast material, were performed on all patients before initiation of antituberculous therapy and repeated 1 month and 6 months later with a Toshiba TCT 600 HQ CT scanner (Toshiba Company, Tokyo, Japan). A single experienced radiologist, blinded to the diagnosis of the patient, evaluated all CT scan results.Clinical characteristics and cytokine levels were compared between patients who did and did not develop IG after completing 1 month and 6 months of therapy. Differences in proportions of categorical variables were evaluated using chisquare or Fisher's exact test when expected cell values were lower than 5. Continuous variables were analyzed using either two-sample Wilcoxon rank-sum (Mann-Whitney) testing for unmatched data or Wilcoxon sign...